The Threat of Science-Related Populism to Global Public Health: Lessons from Iran

Abstract

This manuscript explores the impact of science-related populism on public health during the COVID-19 pandemic, with a focus on the situation in Iran. Our analysis, utilizing publicly available data from The Economist and the World Health Organization, demonstrates the consequences of delayed vaccination campaigns. Statistical analysis shows a clear correlation between delayed vaccine introduction and increased excess mortality rates. This trend is particularly pronounced in Iran, where political resistance to Western vaccine imports and the promotion of unproven medical technologies exacerbated the health crisis. Additionally, our time-series analysis links significant surges in COVID-19 deaths to national events and government decisions that likely enhanced virus transmission, indicating direct public health repercussions from delayed pandemic responses. These results highlight the global security threat posed by science-related populism, where political agendas undermine scientific integrity and public health. The findings advocate for an urgent global commitment to uphold scientific evidence as the cornerstone of health policy, emphasizing the necessity of combating misinformation to ensure timely and effective public health measures.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

留言 (0)

沒有登入
gif